BioQuest Corp.
BQST · OTC
4/30/2025 | 4/30/2024 | 4/30/2023 | 4/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 21.20 | 1.86 | 0.01 |
| FCF Yield | -6.39% | -24.04% | -0.24% | -22.14% |
| EV / EBITDA | -15.43 | -4.88 | -456.30 | -0.91 |
| Quality | ||||
| ROIC | -140.51% | 0.02% | 13.25% | 327.61% |
| Gross Margin | 29.04% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.96 | 0.51 | 0.38 | 0.14 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | – |
| Free Cash Flow Growth | -1,090.38% | -17.16% | 54.16% | 39.59% |
| Safety | ||||
| Net Debt / EBITDA | -0.49 | -1.98 | -3.74 | -0.20 |
| Interest Coverage | 0.00 | -0.00 | -1.18 | -10.40 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -654.34 | 0.00 | 0.00 | -141.76 |